Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
breast cancer
Pharma
Lilly ups oral SERD battle with Inluriyo, Verzenio combo nod
Lilly’s Inluriyo-Verzenio regimen could challenge AstraZeneca’s argument for its novel first-line switch approach with an oral SERD.
Angus Liu
Sep 18, 2026 3:30pm
AZ, Daiichi's Enhertu nabs long-sought NHS blessing from NICE
Sep 16, 2026 7:30pm
AstraZeneca’s Etcamah flunks first-line breast cancer trial
Sep 12, 2026 12:43pm
FDA's surprise approval of AZ's oral SERD sets new paradigm
Sep 8, 2026 10:35am
Celcuity needs facility sign-off to kick off its market launch
Aug 18, 2026 9:26am
Celcuity set to be Big Pharma 'strategic target' after approval
Jul 14, 2026 4:56pm
